FRQND — what changed in the latest 10-Q
A section-by-section comparison of FRQND's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2025-11-19 vs the prior 10-Q · 2025-08-19
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +15 | −12 | ~9 | 33 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3), Legal proceedings, Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2025-11-19
We had net income of $1,648,269 for the three months ended September 30, 2025, compared to $13,383,099 for the three months ended September 30, 2024. The decrease in our net income is primarily due to the change in the fair value of our derivatives.
Results of Operations for the Nine Months ended September 30, 2025 and 2024
We had $1,582,935 in revenue for the nine months ended September 30, 2025, compared to $4,447,273 for the nine months ended September 30, 2024, a decrease of $2,864,338 or 64.4%. The decrease in revenue is primarily due to the Company’s restructuring.
We incurred $3,505,069 in impairment loss for the nine months ended September 30, 2025 compared to $2,117,502 for the nine months ended September 30, 2024.
We had $474,946 of G&A for the nine months ended September 30, 2025, compared to $756,346 for the nine months ended September 30, 2024, a decrease of $281,400 or 37.2%. The decrease in G&A expense is primarily due to the Company’s restructuring.
Text removed vs the prior filing · source: 10-Q · 2025-08-19
Results of Operations for the Six Months ended June 30, 2025 and 2024
We had $1,332,616 in revenue for the six months ended June 30, 2025, compared to $3,411,102 for the six months ended June 30, 2024. The decrease in revenue is primarily due to the Company’s restructuring.
We incurred $303,646 in costs of goods sold for the six months ended June 30, 2025, compared to $1,435,690 for the six months ended June 30, 2024. This decrease is primarily due to the Company’s restructuring.
We had $1,068,957 in compensation for the six months ended June 30, 2025 compared to $2,057,472 of compensation for the six months ended June 30, 2024, a decrease of $988,515 or 48%. The decrease in revenue is primarily due to the Company’s restructuring.
We incurred $283,487 of professional fees for the six months ended June 30, 2025, compared to $388,159 for the six months ended June 30, 2024, a decrease of $104,672 or 27%. Professional fees generally consist of audit, legal, accounting and investor relation service fees. The decrease in the curren…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice